Year archive

RENERVE LIMITED — 2025 filings

All 79 regulatory filings released by RENERVE LIMITED (RNV) in 2025, sourced directly from the official regulator.

79 Filings

2025 Period

2025 filings (79)

Filing	Released	Lang
Maja McGuire appointed as Chair 3 pages 889.2KB Board/Management Information	2025-12-18	English
Notification of cessation of securities - RNV 6 pages 19.1KB Regulatory Filings	2025-12-11	English
Additional information on the DoD & VA agreement 3 pages 233.3KB Capital/Financing Update	2025-12-07	English
ReNerve announces Board changes 3 pages 289.9KB Board/Management Information	2025-12-03	English
Initial Director's Interest Notice - M McGuire 2 pages 4.5KB Director's Dealing	2025-12-03	English
Initial Director's Interest Notice - P Savage 2 pages 4.5KB Director's Dealing	2025-12-03	English
Final Director's Interest Notice - S Cooper 2 pages 292.9KB Director's Dealing	2025-12-03	English
Final Director's Interest Notice - M Panaccio 2 pages 292.0KB Director's Dealing	2025-12-03	English
Correction to Notice of General Meeting/Proxy Form 22 pages 784.9KB Proxy Solicitation & Information Statement	2025-12-02	English
Notification regarding unquoted securities - RNV 15 pages 51.8KB Share Issue/Capital Change	2025-12-01	English
Notice of General Meeting/Proxy Form 17 pages 440.9KB Proxy Solicitation & Information Statement	2025-12-01	English
Change of Director's Interest Notice - J Chick 2 pages 159.0KB Director's Dealing	2025-12-01	English
Change of Director's Interest Notice - D Rhodes 2 pages 151.5KB Director's Dealing	2025-12-01	English
Cleansing Notice 3 pages 227.6KB Capital/Financing Update	2025-11-30	English
Application for quotation of securities - RNV 7 pages 19.3KB Share Issue/Capital Change	2025-11-27	English
ReNerve AGM Presentation 21 pages 2.4MB AGM Information	2025-11-26	English
ReNerve announces Board Renewal Process 2 pages 220.6KB Board/Management Information	2025-11-26	English
Results of Meeting 4 pages 220.7KB Declaration of Voting Results & Voting Rights Announcements	2025-11-26	English
ReNerve completes $3.2m capital raising 4 pages 294.9KB Capital/Financing Update	2025-11-19	English
Proposed issue of securities - RNV 6 pages 21.6KB Capital/Financing Update	2025-11-19	English
Proposed issue of securities - RNV 5 pages 18.6KB Capital/Financing Update	2025-11-19	English
Trading Halt 2 pages 262.4KB Capital/Financing Update	2025-11-17	English
Nerve Cuff approved for use in US DoD and VA hospitals 3 pages 236.0KB Regulatory Filings	2025-11-12	English
Quarterly Investor Presentation 21 pages 2.9MB Investor Presentation	2025-11-09	English
Quarterly Investor Webinar 2 pages 235.0KB Investor Presentation	2025-11-04	English
ReNerve Clinical Study Expansion 3 pages 323.3KB Regulatory Filings	2025-11-04	English
Notice of Annual General Meeting/Proxy Form 62 pages 1.3MB AGM Information	2025-10-28	English
Notification regarding unquoted securities - RNV 13 pages 42.8KB Share Issue/Capital Change	2025-10-23	English
Q1 FY26 Activities Report and Appendix 4C 9 pages 529.2KB Interim / Quarterly Report Q1 2026	2025-10-22	English
ReNerve achieves first sales of amniotic tissue range 3 pages 231.9KB Regulatory Filings	2025-10-13	English
ReNerve products feature in industry forum at ASSH 3 pages 272.5KB Regulatory Filings	2025-10-09	English
Investor Roadshow Presentation 28 pages 3.0MB Regulatory Filings	2025-09-28	English
Change of Director's Interest Notice - S Cooper 2 pages 149.1KB Director's Dealing	2025-09-24	English
Change of Director's Interest Notice - J Chick 2 pages 154.6KB Director's Dealing	2025-09-24	English
ReNerve launches the EmpliQ product ranges 3 pages 271.1KB Capital/Financing Update	2025-09-21	English
Empliq Product Launch 13 pages 1.3MB Investor Presentation	2025-09-21	English
Application for quotation of securities - RNV 8 pages 20.8KB Share Issue/Capital Change	2025-09-16	English
Cleansing Notice 3 pages 224.1KB Capital/Financing Update	2025-09-16	English
Proposed issue of securities - RNV 5 pages 17.2KB Share Issue/Capital Change	2025-09-15	English
ReNerve - Appendix 4E 2 pages 122.8KB Earnings Release FY 2025	2025-08-28	English
ReNerve 2025 Annual Report 51 pages 1.5MB Annual Report FY 2025	2025-08-28	English
ReNerve - Full Year Results 4 pages 291.5KB Annual Report FY 2025	2025-08-28	English
ReNerve - Appendix 4G 12 pages 372.3KB Governance Information	2025-08-28	English
ReNerve - Corporate Governance Statement 8 pages 381.4KB Governance Information	2025-08-28	English
ReNerve records first sale of deep dermal product range 3 pages 269.7KB Regulatory Filings	2025-08-17	English
Quarterly Investor Presentation 15 pages 1.5MB Investor Presentation	2025-08-11	English
Q4 FY25 Activities Report and Appendix 4C 10 pages 564.1KB Interim / Quarterly Report Q4 2025	2025-07-29	English
Quarterly Investor Webinar 2 pages 268.8KB Regulatory Filings	2025-07-29	English
Application for quotation of securities - RNV 8 pages 20.8KB Share Issue/Capital Change	2025-07-13	English
Cleansing Notice 2 pages 224.1KB Capital/Financing Update	2025-07-13	English
Proposed issue of securities - RNV 5 pages 17.2KB Capital/Financing Update	2025-07-10	English
Investor presentation - the Berkeley Biologics Partnership 15 pages 888.4KB Investor Presentation	2025-06-02	English
Expands Product Portfolio with Berkley partnership / Webinar 4 pages 297.8KB Regulatory Filings	2025-06-01	English
ReNerve receives market approval in Bahrain 3 pages 255.8KB Regulatory Filings	2025-05-27	English
Change of Director's Interest Notice - S Cooper 2 pages 36.2KB Director's Dealing	2025-05-08	English
Quarterly Investor Presentation 19 pages 2.1MB Interim / Quarterly Report Q3 2025	2025-05-06	English
Notification regarding unquoted securities - RNV 11 pages 34.7KB Share Issue/Capital Change	2025-04-29	English
ReNerve - Q3 FY25 Activities Report & Appendix 4C 10 pages 589.6KB Interim / Quarterly Report Q3 2025	2025-04-28	English
Quarterly Investor Webinar 2 pages 155.8KB Regulatory Filings	2025-04-28	English
Change in substantial holding 3 pages 283.4KB Major Shareholding Notification	2025-04-16	English
Expands Global Footprint with Strategic Partnership in India 3 pages 263.9KB Capital/Financing Update	2025-04-09	English
Response to ASX Aware Letter 6 pages 387.3KB Regulatory Filings	2025-03-30	English
Clinical Outcome Demonstrates Material Benefits for Patients 5 pages 532.3KB Regulatory Filings	2025-03-27	English
Notification of cessation of securities - RNV 5 pages 16.4KB Capital/Financing Update	2025-03-25	English
Change of Director's Interest Notice - J Chick 2 pages 40.1KB Director's Dealing	2025-03-19	English
Application for quotation of securities - RNV 8 pages 20.7KB Share Issue/Capital Change	2025-03-13	English
Cleansing Notice 2 pages 183.7KB Share Issue/Capital Change	2025-03-13	English
Proposed issue of securities - RNV 5 pages 17.2KB Share Issue/Capital Change	2025-03-12	English
Marketing Approval in Thailand & Initial Sales in Hong Kong 2 pages 271.1KB Regulatory Filings	2025-03-10	English
ReNerve Receives Additional $139K R&D Refund 1 page Capital/Financing Update	2025-03-06	English
1HFY25 Appendix 4D and Half Year Report 23 pages 552.0KB Interim / Quarterly Report H1 2025	2025-02-27	English
1HFY25 Results Announcement 3 pages 208.1KB Interim / Quarterly Report H1 2025	2025-02-27	English
ReNerve enters distribution partnership in Mexico 2 pages 279.5KB Regulatory Filings	2025-02-26	English
Change of Director's Interest Notice - M Panaccio 2 pages 40.4KB Director's Dealing	2025-02-13	English
Change of Director's Interest Notice - J Chick 2 pages 39.9KB Director's Dealing	2025-02-09	English
Quarterly Investor Presentation 14 pages 1.8MB Interim / Quarterly Report Q2 2025	2025-02-05	English
Investor Webinar Update 2 pages 232.9KB Investor Presentation	2025-01-30	English
ReNerve - Q2 FY25 Activities Report & Appendix 4C 12 pages 903.6KB Interim / Quarterly Report Q2 2025	2025-01-28	English
Becoming a substantial holder 3 pages 128.2KB Major Shareholding Notification	2025-01-08	English